Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pituitary Gland Carcinoma”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)UnknownNCT01849484
What this trial is testing

Enhancement of Neurocognitive Functions by Hippocampal Sparing Radiotherapy

Who this might be right for
Radiation of Neurocranial Region
University of Erlangen-Nürnberg Medical School 150
Not applicableUnknownNCT02854228
What this trial is testing

PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon

Who this might be right for
Pituitary Tumor
Hospices Civils de Lyon 1,300
Testing effectiveness (Phase 2)Active Not RecruitingNCT03604198
What this trial is testing

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Who this might be right for
Cushing Syndrome
Corcept Therapeutics 125
Large-scale testing (Phase 3)Study completedNCT00936741
What this trial is testing

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 30
Large-scale testing (Phase 3)Study completedNCT00569582
What this trial is testing

The Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 50
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT02804750
What this trial is testing

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 35
Testing effectiveness (Phase 2)WithdrawnNCT04106843
What this trial is testing

Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers

Who this might be right for
Locally Advanced Adrenal Gland PheochromocytomaLocally Advanced ParagangliomaMetastatic Adrenal Gland Pheochromocytoma+11 more
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00446082
What this trial is testing

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Who this might be right for
Carcinoid TumorAcromegaly
Novartis Pharmaceuticals 85
Not applicableLooking for participantsNCT06523582
What this trial is testing

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Who this might be right for
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more
Universidad Nacional Autonoma de Mexico 750
Testing effectiveness (Phase 2)WithdrawnNCT00003514
What this trial is testing

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Who this might be right for
Merkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more
Burzynski Research Institute
Not applicableActive Not RecruitingNCT03583528
What this trial is testing

DOTATOC PET/CT for Imaging NET Patients

Who this might be right for
Neuroendocrine TumorsInsulinomaGastrinoma+13 more
British Columbia Cancer Agency 800
Not applicableLooking for participantsNCT06973824
What this trial is testing

A Twenty-years' Experience in Pituitary Disease.

Who this might be right for
Pituitary AdenomaPituitary CancerPituitary Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,600
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableLooking for participantsNCT03382158
What this trial is testing

International PPB/DICER1 Registry

Who this might be right for
Pleuropulmonary BlastomaSertoli-Leydig Cell TumorDICER1 Syndrome+16 more
Children's Hospitals and Clinics of Minnesota 3,400
Testing effectiveness (Phase 2)Active Not RecruitingNCT04042753
What this trial is testing

Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

Who this might be right for
PituitaryPituitary TumorPituitary Carcinoma+1 more
Memorial Sloan Kettering Cancer Center 9
Not applicableEnded earlyNCT00796783
What this trial is testing

Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 2
Not applicableStudy completedNCT00390962
What this trial is testing

The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)

Who this might be right for
StrokeTransient Ischemic Attack
University Hospital, Basel, Switzerland 469